FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $361 | -95.5% | 139 | -95.7% | 0.00% | – |
| Q2 2022 | $8,000 | +60.0% | 3,259 | +180.9% | 0.00% | – |
| Q4 2021 | $5,000 | -76.2% | 1,160 | -56.3% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | -12.5% | 2,654 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | +41.2% | 3,015 | +93.5% | 0.00% | – |
| Q1 2021 | $17,000 | – | 1,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 2,973,744 | $24,028,000 | 4.99% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,598,377 | $12,613,000 | 4.97% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $29,658,000 | 3.03% |
| Sio Capital Management, LLC | 266,107 | $2,150,000 | 0.53% |
| Orbimed Advisors | 3,224,770 | $26,056,000 | 0.26% |
| Perceptive Advisors | 3,550,334 | $28,686,000 | 0.19% |
| AlphaCentric Advisors LLC | 71,500 | $578,000 | 0.16% |
| Rock Springs Capital Management LP | 948,327 | $7,662,000 | 0.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $20,618,000 | 0.15% |
| Artal Group S.A. | 750,000 | $6,060,000 | 0.12% |